Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate

Follow Us

News Trending Portfolio

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

STOCKS

Plans & Pricing

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

Best Cannabis & Marijuana Stocks

Best cannabis & marijuana stocks for 2023. Cannabis is a plant that can be used to treat, manage, or improve medical symptoms. It is also used for recreational purposes, given its psychoactive properties. Also known as marijuana, weed, and other names, it has become legal or decriminalized in most U.S. states, Canada, and other places. Consumers are becoming more accepting of cannabis, appreciating its medicinal and recreational properties. This has led to a slew of companies that research, develop, and distribute medical and recreational marijuana. As a result, the marijuana industry is projected to double in value by 2025, making it popular with investors. This list covers the best cannabis companies.

Compare up to 10 stocks

CGC MO ABBV SMG JAZZ HEXO CURLF GTBIF TCNNF

Comparison Results

Name	Price	Volume	Analyst Price Target	Analyst Consensus	Smart Score	Market Cap	P/E Ratio	Dividend Yield	Sector	Article	Follow
CGC Canopy Growth	$3.98	213.89K	xxxxxxxxxxxxx	0 Buy 0 Hold 1 Sell Moderate Sell		$495.11M	-0.78	―	Healthcare
MO Altria Group	$56.37	261.62K	xxxxxxxxxxxxx	3 Buy 2 Hold 2 Sell Hold		$94.96B	9.46	7.07%	Consumer Defensive
ABBV AbbVie	$175.51	516.92K	xxxxxxxxxxxxx	13 Buy 7 Hold 0 Sell Moderate Buy		$303.47B	59.89	3.69%	Healthcare
SMG Scotts Miracle-Gro Company	$76.79	12.54K	xxxxxxxxxxxxx	2 Buy 3 Hold 0 Sell Moderate Buy		$4.35B	-111.41	3.51%	Basic Materials
JAZZ Jazz Pharmaceuticals	$126.76	23.47K	xxxxxxxxxxxxx	14 Buy 3 Hold 0 Sell Strong Buy		$7.56B	18.02	―	Healthcare
CURLF Curaleaf Holdings	$1.96	23.47K	xxxxxxxxxxxxx	3 Buy 2 Hold 0 Sell Moderate Buy		$1.49B	-7.30	―	Healthcare
GTBIF Green Thumb Industries	$9.23	8.53K	xxxxxxxxxxxxx	3 Buy 0 Hold 0 Sell Strong Buy		$2.20B	35.24	―	Healthcare
TCNNF Trulieve Cannabis	$6.10	17.36K	xxxxxxxxxxxxx	3 Buy 1 Hold 0 Sell Strong Buy		$1.16B	-8.21	―	Healthcare
HEXO	―	―	xxxxxxxxxxxxx	―		―	―	―	―

Performance Comparison

CGC

Canopy Growth

3.86

-1.91

-33.10%

MO

Altria Group

56.03

18.25

48.31%

ABBV

AbbVie

171.73

38.14

28.55%

SMG

Scotts Miracle-Gro Company

76.48

22.64

42.05%

JAZZ

Jazz Pharmaceuticals

125.10

3.38

2.78%

HEXO

―

―

―

―

CURLF

Curaleaf Holdings

1.99

-1.65

-45.33%

GTBIF

Green Thumb Industries

9.34

-0.93

-9.06%

TCNNF

Trulieve Cannabis

6.12

0.37

6.43%

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Cannabis Stocks Latest News

Trulieve Expands with New Jacksonville Dispensary

Trulieve Expands with New Jacksonville Dispensary

Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis is opening a new medical cannabis dispensary in Jacksonville,...

17m ago

AbbVie upgraded, Baidu downgraded: Wall Street’s top analyst calls

AbbVie upgraded, Baidu downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

18m ago

Largest borrow rate increases among liquid names

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: SPIRIT AIRLINES INC. (SAVEQ)...

1h ago

Green Thumb expands national retail footprint to over 100 stores nationwide

Green Thumb expands national retail footprint to over 100 stores nationwide

RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries (GTBIF), announced the opening of its landmark...

3h ago

AbbVie upgraded to Outperform from Market Perform at Leerink

AbbVie upgraded to Outperform from Market Perform at Leerink

Leerink analyst David Risinger upgraded AbbVie (ABBV) to Outperform from Market Perform with a $206 price target The...

4h ago

AbbVie upgraded to Outperform from Market Perform at Leerink

AbbVie upgraded to Outperform from Market Perform at Leerink

Leerink upgraded AbbVie (ABBV) to Outperform from Market Perform with a $206 price target Published first on TheFly...

4h ago

FDA grants accelerated approval to Jazz Pharmaceuticals’ Ziihera

FDA grants accelerated approval to Jazz Pharmaceuticals’ Ziihera

The Food and Drug Administration granted accelerated approval to zanidatamab-hrii, or Ziihera from Jazz Pharmaceuticals (JAZZ), Inc., a...

22h ago

Rising High: Numinus Wellness to sell five Utah clinics for $3.53M

Rising High: Numinus Wellness to sell five Utah clinics for $3.53M

In this week’s “Rising High,” The Fly’s recurring series focused on cannabis and psychedelic stock news, The Fly...

23h ago

Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler

Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler

Piper Sandler lowered the firm’s price target on Jazz Pharmaceuticals (JAZZ) to $163 from $166 and keeps an...

1d ago

Zymeworks, Jazz Pharmaceuticals announce FDA approval of Ziihera

Zymeworks, Jazz Pharmaceuticals announce FDA approval of Ziihera

Zymeworks (ZYME) announced, with Jazz Pharmaceuticals (JAZZ), that the U.S. FDA has granted accelerated approval of Ziihera 50mg/mL...

1d ago

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Cannabis Stocks

Jazz Pharmaceuticals

Buy

Assigned

2024-11-22

Altria Group

Buy

Reiterated

2024-11-21

AbbVie

Buy

Reiterated

2024-11-18

Scotts Miracle-Gro Company

Hold

Reiterated

2024-11-15

Green Thumb Industries

Buy

Reiterated

2024-11-12

Curaleaf Holdings

Buy

Reiterated

2024-11-11

Canopy Growth

Sell

Reiterated

2024-11-08

Trulieve Cannabis

Buy

Reiterated

2024-11-07

Jazz Pharmaceuticals

Buy

Reiterated

2024-11-21

Jazz Pharmaceuticals

Buy

Reiterated

2024-11-21

Most Recent Earnings of Cannabis Stocks

Canopy Growth

Nov 08, 2024

Sep 01, 2024

-0.35 / -1.05

-1.858

Altria Group

Oct 31, 2024

Sep 01, 2024

1.35 / 1.38

1.18

AbbVie

Oct 30, 2024

Sep 01, 2024

2.92 / 3.00

2.79

Scotts Miracle-Gro Company

Nov 06, 2024

Sep 01, 2024

-1.96 / -2.31

-1.45

Jazz Pharmaceuticals

Nov 06, 2024

Sep 01, 2024

5.50 / 6.61

5.02

Curaleaf Holdings

Nov 06, 2024

Sep 01, 2024

-0.06 / -0.07

-0.057

Green Thumb Industries

Nov 07, 2024

Sep 01, 2024

0.07 / 0.04

0.007

Trulieve Cannabis

Nov 05, 2024

Sep 01, 2024

-0.11 / -0.32

-0.129

HEXO

―

―

―

- / -

―

Cannabis Stocks - FAQ

Which Cannabis stocks have a "Strong Buy" analyst rating?

These Cannabis stocks currently have a "Strong Buy" analyst rating consensus:

Jazz Pharmaceuticals - Strong Buy, based on 17 analyst ratings, 14 Buy, 3 Hold, and 0 Sell.

Green Thumb Industries - Strong Buy, based on 3 analyst ratings, 3 Buy, 0 Hold, and 0 Sell.

Trulieve Cannabis - Strong Buy, based on 4 analyst ratings, 3 Buy, 1 Hold, and 0 Sell.

Are Cannabis stocks overpriced?

Canopy Growth's stock price is currently $3.98, and its average 12-month price target is $3.55.

Altria Group's stock price is currently $56.37, and its average 12-month price target is $52.57.

AbbVie's stock price is currently $175.51, and its average 12-month price target is $205.81.

Scotts Miracle-Gro Company's stock price is currently $76.79, and its average 12-month price target is $80.00.

Jazz Pharmaceuticals's stock price is currently $126.76, and its average 12-month price target is $178.82.

Curaleaf Holdings's stock price is currently $1.96, and its average 12-month price target is $4.01.

Green Thumb Industries's stock price is currently $9.23, and its average 12-month price target is $16.34.

Trulieve Cannabis's stock price is currently $6.10, and its average 12-month price target is $19.76.

's stock price is currently N/A, and its average 12-month price target is N/A.

Which Cannabis stocks pay dividends?

Canopy Growth does not currently pay dividends.

Altria Group does not currently pay dividends.

AbbVie currently pays a dividend of $1.64 which represents an annual dividend yield of 3.69%. AbbVie's next Ex-dividend date is January 15, 2025 and its next payout date is February 14, 2025.

Scotts Miracle-Gro Company does not currently pay dividends.

Jazz Pharmaceuticals does not currently pay dividends.

Curaleaf Holdings does not currently pay dividends.

Green Thumb Industries does not currently pay dividends.

Trulieve Cannabis does not currently pay dividends.

does not currently pay dividends.